10-60072055-G-A
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP7
The NM_020987.5(ANK3):c.8826C>T(p.Gly2942Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,613,928 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
 Genomes: 𝑓 0.000020   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.000013   (  0   hom.  ) 
Consequence
 ANK3
NM_020987.5 synonymous
NM_020987.5 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.436  
Publications
0 publications found 
Genes affected
 ANK3  (HGNC:494):  (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011] 
ANK3 Gene-Disease associations (from GenCC):
- intellectual disability-hypotonia-spasticity-sleep disorder syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- intellectual disabilityInheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
- Tourette syndromeInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86). 
BP7
Synonymous conserved (PhyloP=-0.436 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000197  AC: 3AN: 152168Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
3
AN: 
152168
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000200  AC: 5AN: 250624 AF XY:  0.0000148   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
5
AN: 
250624
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000130  AC: 19AN: 1461760Hom.:  0  Cov.: 36 AF XY:  0.0000124  AC XY: 9AN XY: 727184 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
19
AN: 
1461760
Hom.: 
Cov.: 
36
 AF XY: 
AC XY: 
9
AN XY: 
727184
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33472
American (AMR) 
 AF: 
AC: 
0
AN: 
44708
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26128
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39684
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
86256
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53380
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5764
European-Non Finnish (NFE) 
 AF: 
AC: 
16
AN: 
1111976
Other (OTH) 
 AF: 
AC: 
2
AN: 
60392
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.454 
Heterozygous variant carriers
 0 
 1 
 3 
 4 
 6 
 7 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000197  AC: 3AN: 152168Hom.:  0  Cov.: 32 AF XY:  0.0000404  AC XY: 3AN XY: 74342 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
3
AN: 
152168
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
3
AN XY: 
74342
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41432
American (AMR) 
 AF: 
AC: 
1
AN: 
15276
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5198
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
4828
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10620
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
68030
Other (OTH) 
 AF: 
AC: 
0
AN: 
2090
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.425 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Uncertain significance 
Submissions summary: Uncertain:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not specified    Uncertain:1 
Oct 11, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.